O'Donnell JM - Search Results

1

Dynamic 13C NMR analysis of oxidative metabolism in the in vivo canine myocardium.

Robitaille PM, Rath DP, Abduljalil AM, O'Donnell JM, Jiang Z, Zhang H, Hamlin RL. Robitaille PM, et al. J Biol Chem. 1993 Dec 15;268(35):26296-301. J Biol Chem. 1993. PMID: 8253751 Free article.

2

Effects of rolipram on scopolamine-induced impairment of working and reference memory in the radial-arm maze tests in rats.

Zhang HT, O'Donnell JM. Zhang HT, et al. Psychopharmacology (Berl). 2000 Jun;150(3):311-6. doi: 10.1007/s002130000414. Psychopharmacology (Berl). 2000. PMID: 10923759

3

Phosphorus-31 magnetic resonance spectroscopy studies of pig spinal cord injury. Myelin changes, intracellular pH, and bioenergetics.

Akino M, O'Donnell JM, Robitaille PM, Stokes BT. Akino M, et al. Invest Radiol. 1997 Jul;32(7):382-8. doi: 10.1097/00004424-199707000-00003. Invest Radiol. 1997. PMID: 9228603

4

Antidepressant effects of inhibitors of cAMP phosphodiesterase (PDE4).

O'Donnell JM, Zhang HT. O'Donnell JM, et al. Trends Pharmacol Sci. 2004 Mar;25(3):158-63. doi: 10.1016/j.tips.2004.01.003. Trends Pharmacol Sci. 2004. PMID: 15019272 Review. No abstract available.

5

Dual inhibitors of phosphodiesterase-4 and serotonin reuptake.

Cashman JR, Voelker T, Zhang HT, O'Donnell JM. Cashman JR, et al. J Med Chem. 2009 Mar 26;52(6):1530-9. doi: 10.1021/jm8010993. J Med Chem. 2009. PMID: 19256502 Free PMC article.

6

Design and Synthesis of Selective Phosphodiesterase 4D (PDE4D) Allosteric Inhibitors for the Treatment of Fragile X Syndrome and Other Brain Disorders.

Gurney ME, Nugent RA, Mo X, Sindac JA, Hagen TJ, Fox D 3rd, O'Donnell JM, Zhang C, Xu Y, Zhang HT, Groppi VE, Bailie M, White RE, Romero DL, Vellekoop AS, Walker JR, Surman MD, Zhu L, Campbell RF. Gurney ME, et al. J Med Chem. 2019 May 23;62(10):4884-4901. doi: 10.1021/acs.jmedchem.9b00193. Epub 2019 Apr 23. J Med Chem. 2019. PMID: 31013090 Free PMC article.

7

Inhibitor binding to type 4 phosphodiesterase (PDE4) assessed using [3H]piclamilast and [3H]rolipram.

Zhao Y, Zhang HT, O'Donnell JM. Zhao Y, et al. J Pharmacol Exp Ther. 2003 May;305(2):565-72. doi: 10.1124/jpet.102.47407. J Pharmacol Exp Ther. 2003. PMID: 12704225

8

Antagonism of the antidepressant-like effects of clenbuterol by central administration of beta-adrenergic antagonists in rats.

Zhang HT, Huang Y, O'Donnell JM. Zhang HT, et al. Psychopharmacology (Berl). 2003 Oct;170(1):102-7. doi: 10.1007/s00213-003-1512-0. Epub 2003 Jul 25. Psychopharmacology (Berl). 2003. PMID: 12898120

9

Antidepressant-induced increase in high-affinity rolipram binding sites in rat brain: dependence on noradrenergic and serotonergic function.

Zhao Y, Zhang HT, O'Donnell JM. Zhao Y, et al. J Pharmacol Exp Ther. 2003 Oct;307(1):246-53. doi: 10.1124/jpet.103.053215. Epub 2003 Sep 3. J Pharmacol Exp Ther. 2003. PMID: 12954819

10

Inhibition of cyclic AMP phosphodiesterase (PDE4) reverses memory deficits associated with NMDA receptor antagonism.

Zhang HT, Crissman AM, Dorairaj NR, Chandler LJ, O'Donnell JM. Zhang HT, et al. Neuropsychopharmacology. 2000 Aug;23(2):198-204. doi: 10.1016/S0893-133X(00)00108-1. Neuropsychopharmacology. 2000. PMID: 10882846

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

358 results

Search Page

Filters